Logo image of MREO

MEREO BIOPHARMA GROUP PL-ADR (MREO) Stock Earnings & Estimates

NASDAQ:MREO - US5894921072 - ADR

1.7 USD
+0.05 (+3.03%)
Last: 8/22/2025, 8:25:11 PM
1.76 USD
+0.06 (+3.53%)
Pre-Market: 8/25/2025, 8:50:22 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
MREO revenue by date.MREO revenue by date.
50.14M
-100.00%
10M
-100.00%
24.323M37.823M
55.50%
102.08M
169.89%
160.02M
56.76%
249.84M
56.13%
363.83M
45.63%
508.82M
39.85%
644.39M
26.64%
EBITDA
YoY % growth
MREO ebitda by date.MREO ebitda by date.
-27.905M
39.49%
-52.781M
-89.15%
-27.355M
48.17%
-53.026M
-69.17%
-19.863M
57.08%
743.876K
103.75%
22.803M
2,965.43%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
MREO ebit by date.MREO ebit by date.
-28.788M
40.24%
-53.677M
-86.46%
-28.416M
47.06%
-43.817M
-66.68%
-33.399M
29.49%
-27.541M
17.54%
459.428K
101.67%
42.927M
9,243.57%
114.1M
165.80%
206.75M
81.20%
332.94M
61.04%
449.82M
35.11%
Operating Margin
MREO operating margin by date.MREO operating margin by date.
-57.42%N/A-284.16%N/A-137.31%-72.81%0.45%26.83%45.67%56.83%65.43%69.81%
EPS
YoY % growth
MREO eps by date.MREO eps by date.
N/A
88.68%
N/A
-47.54%
N/A
38.67%
-0.06
-8.58%
-0.06
-9.51%
-0.05
18.41%
-0.01
80.65%
0.04
498.00%
0.11
164.57%
0.19
80.06%
0.33
68.67%
0.44
35.87%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.03
66.85%
0.02
133.16%
-0.02
84.43%
-0.02
84.43%
-0.02
30.00%
-0.01
-146.15%
Revenue
Q2Q % growth
11.9M22.015M12.75M
2,450.00%

-100.00%
27.343M
24.20%
EBITDA
Q2Q % growth
-12.24M
-43.01%
38.76M
373.21%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-5.94M
36.62%
4.602M
130.13%
-13.711M
-24.65%
-4.892M
51.08%
-15.639M
-163.28%
3.741M
-18.71%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.10
-26.18%
-0.02-0.08-499.63%
Q1 2025
Q2Q % growth
-0.10 -0.01-0.09-1,246.69%
Q4 2024
Q2Q % growth
-0.05
-19,503.92%
-0.01-0.04-240.11%
Q3 2024
Q2Q % growth
-0.08 -0.01-0.06-449.62%
Q2 2024
Q2Q % growth
-0.08
-38,748.04%
-0.01-0.07-886.64%
MREO Yearly EPS VS EstimatesMREO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 0.4 -0.4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
19.063M-19.063M-100.00%
Q4 2024
Q2Q % growth

-100.00%
%
Q2 2024
Q2Q % growth

-100.00%
%
Q4 2023
Q2Q % growth
10M 37.23M-27.23M-73.14%
Q2 2022
Q2Q % growth

-100.00%
%
MREO Yearly Revenue VS EstimatesMREO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2023 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-19.27% 84.68% -18.39% -25.76%
Revenue-34.88% N/A 4.01% 2.77%